Shiro Kuniya - NEXON Co Independent Director
| 7NX Stock | EUR 12.60 0.20 1.56% |
Director
Mr. Shiro Kuniya was serving as Independent Director in NEXON Co., Ltd. since March 27, 2012. He is also working for a law firm, a hospital, the Japan Commercial Arbitration Association and Japan Century Symphony Orchestra, as well as serving as Director of Ebara Corporationration, Takeda Pharmaceutical Company Limited and Sony Financial Holdings Inc. since 2012.
| Age | 62 |
| Tenure | 12 years |
Similar Executives
| Found 1 records | DIRECTOR Age | ||
| Michele Holcomb | KIMBALL ELECTRONICS | 51 | |
NEXON Co Leadership Team
Elected by the shareholders, the NEXON Co's board of directors comprises two types of representatives: NEXON Co inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NEXON. The board's role is to monitor NEXON Co's management team and ensure that shareholders' interests are well served. NEXON Co's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NEXON Co's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patrick Soderlund, Independent Director | ||
| Owen Mahoney, President, Chief Executive Officer, Representative Director | ||
| Shiro Uemura, Chief Financial Officer, Chief Director of Business Administration, Representative Director | ||
| Dohwa Lee, Director | ||
| Shiro Kuniya, Independent Director | ||
| Satoshi Honda, Independent Director |
NEXON Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NEXON Co a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 14.65 B | |||
| Price To Book | 2.92 X | |||
| Price To Sales | 8.12 X | |||
| Revenue | 274.46 B | |||
| EBITDA | 145.29 B | |||
| Net Income | 114.89 B | |||
| Cash Flow From Operations | 105.91 B | |||
| Market Capitalization | 15.81 B | |||
| Total Asset | 986.63 B | |||
| Annual Yield | 0.16 % |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NEXON Stock Analysis
When running NEXON Co's price analysis, check to measure NEXON Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NEXON Co is operating at the current time. Most of NEXON Co's value examination focuses on studying past and present price action to predict the probability of NEXON Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NEXON Co's price. Additionally, you may evaluate how the addition of NEXON Co to your portfolios can decrease your overall portfolio volatility.